Immunogenicity, safety, and reactogenicity of combined reduced-antigen-content diphtheria-tetanus-acellular pertussis vaccine administered as a booster vaccine dose in healthy Russian participants: a phase III, open-label study

Immunogenicity, safety, and reactogenicity of combined reduced-antigen-content diphtheria-tetanus-acellular pertussis vaccine administered as a booster vaccine dose in healthy Russian participants: a phase III, open-label study

As vaccine-induced immunity and protection following natural pertussis infection wane over time, adults and adolescents may develop pertussis and become transmitters to unprotected infants. In Russia, diphtheria and tetanus but not pertussis-containing vaccines are registered for older children, ado...

Full description

Bibliographic Details
Main Authors: Asmik Asatryan, Nadia Meyer, Michael Scherbakov, Victor Romanenko, Irina Osipova, Anna Galustyan, Olga Shamsheva, Tatiana Latysheva, Tatyana Myasnikova, Nathalie Baudson, Monique Dodet, Stebin Xavier, Lauriane Harrington, Anastasia Kuznetsova, Laura Campora, Peter Van den Steen
Format: Article
Language:English
Published: Taylor & Francis Group 2021-03-01
Series:Human Vaccines & Immunotherapeutics
Subjects:
acellular pertussis
diphtheria
tetanus
booster vaccination
immunogenicity
reactogenicity
safety
Online Access:http://dx.doi.org/10.1080/21645515.2020.1796423

Internet

http://dx.doi.org/10.1080/21645515.2020.1796423

Similar Items